1566-15-0

1566-15-0 structure

Name: Phosphoramide mustard (cyclohexanamine)
Chemical Name: amino-[bis(2-chloroethyl)amino]phosphinic acid,cyclohexanamine
CAS Number: 1566-15-0
Molecular Formula: C₁₀H₂₄Cl₂N₃O₂P
Molecular Weight: 320.19600
Catalog: Signaling Pathways Cell Cycle/DNA Damage DNA Alkylator/Crosslinker
Create Date: 2016-01-30 18:35:29
Modify Date: 2024-01-17 10:11:02
Phosphoramide mustard cyclohexanamine is the major metabolite for Cyclophosphamide (HY-17420), with anticancer activitiy. Phosphoramide mustard cyclohexanamine induces DNA adduct formation in ovarian granulosa cells, induces DNA damage and elicits the ovarian DNA repair response[1][2].

Name	amino-[bis(2-chloroethyl)amino]phosphinic acid,cyclohexanamine
Synonyms	n,n-bis(2-chloroethyl)phosphorodiamidic acid-cyclohexanamine(1:1) Phosphorodiamidic acid,N,N-bis(2-chloroethyl)-,cyclohexylamine salt phosphoramide mustard cyclohexylammonium salt Cyclohexylammonium Hydrogen N,N-di-(2-chloroethyl)phosphorodiamidate Phosphoramide mustard cyclohexamine salt phosphoramide mustard cyclohexylamine salt Phosphorodiamidic acid,N,N-bis(2-chloroethyl)-,compd. with cyclohexanamine (1:1) OMF 59 cyclohexylamine,salt of/the/ N,N-bis-(2-chloro-ethyl)-diamidophosphoric acid Cyclohexylamin,Salz der N,N-Bis-(2-chlor-aethyl)-diamidophosphorsaeure N,N-bis(2-chloroethyl)phosphorodiamidic acid cyclohexylammonium salt

Description	Phosphoramide mustard cyclohexanamine is the major metabolite for Cyclophosphamide (HY-17420), with anticancer activitiy. Phosphoramide mustard cyclohexanamine induces DNA adduct formation in ovarian granulosa cells, induces DNA damage and elicits the ovarian DNA repair response[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> DNA Alkylator/Crosslinker
In Vitro	Phosphoramide mustard cyclohexanamine causes cytotoxicity through forming cross-linked DNA adducts which inhibit DNA strand separation during replication[1]. Phosphoramide mustard cyclohexanamine destroys rapidly dividing cells by forming NOR-G-OH, NOR-G and G-NOR-G adducts with DNA, potentially leading to DNA damage[1]. Phosphoramide mustard cyclohexanamine (3-6 μM; 48 hours) reduces cell viability in rat spontaneously immortalized granulosa cells (SIGCs)[1]. Phosphoramide mustard cyclohexanamine (3-6 μM; 24-48 hours) induces DNA adduct formation[1]. Phosphoramide mustard cyclohexanamine (3-6 μM; 24-48 hours) induces ovarian DNA damage in rat ovaries[1]. Phosphoramide mustard cyclohexanamine increases DNA damage responses (DDR) gene (Atm, Parp1, Prkdc, Xrcc6, Brca1, Rad51) mRNA expression level[1]. Phosphoramide mustard cyclohexanamine (3-6 μM; 24-48 hours) increased DDR proteins[1]. Cell Viability Assay[1] Cell Line: SIGCs Concentration: 0.5 μM, 1 μM, 3 μM, 6 μM Incubation Time: 48 hours Result: Reduced cell viability at concentrations of 3 μM and higher. RT-PCR[1] Cell Line: SIGCs Concentration: 3 μM, 6 μM Incubation Time: 24 hours, 48 hours Result: Increased DDR gene mRNA expression levels. Western Blot Analysis[1] Cell Line: SIGCs Concentration: 3 μM, 6 μM Incubation Time: 24 hours, 48 hours Result: Generally increased DDR proteins.
In Vivo	Phosphoramide mustard cyclohexanamine (2.1-20.7 mg/kg; i.p.; daily; for 5 days) inhibits subcutaneous tumor growth in rats[2]. Phosphoramide mustard cyclohexanamine (86.0 mg/kg; i.v.) has a plasma disappearance half-life of 15.1 minutes[2]. Animal Model: Rat, subcutaneously implanted Walker 256 carcinosarcoma tumor[2] Dosage: 2.1 mg/kg, 4.8 mg/kg, 10.4 mg/kg, 20.7 mg/kg Administration: Intraperitoneal injection, once daily, for 5 consecutive days Result: Required to produce 50% inhibition of subcutaneous tumor growth with dose of 12 mg/kg. Animal Model: Rats[2] Dosage: 86.0 mg/kg (Pharmacokinetic Analysis) Administration: Intravenous injection Result: Had a disappearance half-life of 15.1 minutes in plasma.
References	[1]. Shanthi Ganesan, et al. Phosphoramide mustard exposure induces DNA adduct formation and the DNA damage repair response in rat ovarian granulosa cells. Toxicol Appl Pharmacol. 2015 Feb 1; 282(3): 252–258. [2]. S Genka, et al. Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the rat. Cancer Chemother Pharmacol. 1990;27(1):1-7.

Boiling Point	363.5ºC at 760mmHg
Melting Point	100-103 °C
Molecular Formula	C₁₀H₂₄Cl₂N₃O₂P
Molecular Weight	320.19600
Flash Point	173.6ºC
Exact Mass	319.09800
PSA	102.39000
LogP	3.50350
Vapour Pressure	2.84E-06mmHg at 25°C

1566-15-0	5776-49-8
10159-53-2	57154-91-3
13597-72-3	879-61-8
105555-57-5	69020-37-7
38770-09-1	63918-37-6
1158522-08-7	940364-43-2
134104-43-1	131615-57-1
6906-52-1	1211538-58-7
874145-80-9	874354-12-8
930439-75-1	1270385-79-9